Navigation Links
Genesis Biopharma Announces Letter to Shareholders Posted to Website
Date:8/30/2011

cal participation and guidance from these distinguished professionals is an invaluable asset for Genesis Biopharma.   This Board includes:

  • Cassian Yee, M.D., of the Fred Hutchinson Cancer Research Center
  • James Mule, Ph.D. and Jeffrey Weber, M.D., Ph.D., of the H. Lee Moffitt Cancer Center & Research Institute
  • Patrick Hwu, M.D. and Laszlo Radvanyi, Ph.D., of MD Anderson Cancer Center
  • Daniel Powell, Ph.D., of the University of Pennsylvania School of Medicine
  • Mario Sznol, M.D., of Yale University School of Medicine
  • David DiGiusto, Ph.D., of the City of Hope

As we look forward to the remainder of 2011 and beyond, we believe Contego will continue to progress rapidly through manufacturing scale-up and the regulatory processes, and will become a life-saving therapy available to all metastatic melanoma patients at the major cancer medical centers in the U.S. and eventually, worldwide.

Thank you for your continued support as we work to bring life saving cancer treatments to patients worldwide.  

Sincerely,

Anthony J. Cataldo

Chairman and Chief Executive Officer

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is engaged in the development and commercialization of a novel autologous cell therapy (ACT) for the treatment of various cancers.  ACT using tumor infiltrating lymphocyte (TILs) is currently a standard therapy for treating Stage IV metastatic melanoma at the National Cancer Institute and leading institutions such as University of Texas MD Anderson Cancer Center in Houston and the H. Lee Moffitt Cancer Center in Tampa.

Within the next twelve months, Genesis Biopharma expects to initiate a pivotal clinical trial with its lead product candidate, Contego™, an autologous cell therapy using TILs as a second line treatment for Stage IV metastatic melanoma and thereafter to conduct a conf
'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
2. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
3. Genesis Biopharma to Hold Business Update Conference Call on June 29
4. ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference
5. Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes
6. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
7. CryoLife Announces Completion of Acquisition of Cardiogenesis
8. CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
9. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
10. Cardiogenesis Reports First Quarter 2011 Results
11. CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... PARK, N.J. , July 30, 2015  Unichem ... voluntarily recalling one lot of Hydrochlorothiazide tablets 25 mg ... been initiated as a precautionary measure due to the ... of the product. The risk associated ... Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel,s ...
(Date:7/30/2015)... N.J., July 30, 2015 PTC Therapeutics, Inc. ... and reported financial results for the second quarter ending ... on many fronts across the organization.  We are excited ... muscular dystrophy clinical trial ever conducted with topline results ... Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is ...
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... keynote address last month that industry is compelled to ... to gain the efficiencies—and develop the transformational innovations -- ... Barsoum,s comments were preceded by Doug Kohrs , ... OMTEC moderator, who stressed that industry must add "episode ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company ... on the early diagnosis and preventive treatment of cardiometabolic ... selected by Windhover as one of the "Top Biopharma ... This announcement is part of the conference event organized ...
... Pasteur, the vaccines division of the sanofi-aventis Group ... announced today the results of the Phase III ... Virus Vaccine) candidate compared to Fluzone (Influenza Virus ...  Data from the clinical trial assessing the immunogenicity ...
Cached Medicine Technology:GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 3Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine 2Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine 3Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine 4Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine 5
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly ... for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, ... delete any message including ones already sent. , While text messaging has more features ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the STASH awards ... awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in ... products that have stood the test of time. These include lighting products, organic ...
(Date:7/31/2015)... New York (PRWEB) , ... July 31, 2015 , ... ... strut their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) ... trademark application in process. , To commemorate introduction of this new type of sod, ...
(Date:7/31/2015)... CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will ... National Football League’s biggest day each year is the Super Bowl. In the two weeks ... takes place from the host venue. The 2016 Super Bowl game will mark the 50th ...
(Date:7/31/2015)... ... 2015 , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle ... provider of Exilis non-surgical fat reduction in New York. Due to its unparalleled ... International clientele. Many patients travel to New York to get their non-surgical skin ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... kids spend in exercise will not guarantee that they will ... of Cornell University and colleagues found in a new study ... in physical education decreased from 42% in 1991 to 33% ... teens in grades nine through 12. All students had taken ...
... are highly sensitive to allergies in the first three years ... ,Sabina Illi and colleagues at the University Children's Hospital, ... to allergens in early life and the effect of the ... asthma. They had reported their findings in the latest issue ...
... keeping their appointments with their doctors and practice nurses every ... ,The poll revealed that over 11 million appointments with ... appointments were missed in UK last year. The problem is ... and the West Midlands are just behind. The survey was ...
... disclosed that a specific variety of adult ... neurons or other// types of tissue depending on the ... ,The researchers found that mesenchymal stem cells, which are ... clues from their local environment, allowing a transformation into ...
... Kerr, praised the services of NHS 24 helpline service ... that the confidence on the Scotland's// health service phone ... with out-of-hours health inquiries had come under severe criticism ... crucial time delays in the service rendered by the ...
... 30 years, the number of cervical cancer deaths in the ... year. The main reason for the decrease is the Pap// ... has entered a new era, with the FDA’s recent approval ... strains of this virus cause nearly all cervical cancers. Although ...
Cached Medicine News:Health News:Babies Prone To Allergies More likely To Be Asthmatic 2Health News:Adult stem cells are sensitive to responses from the environment 2Health News:NHS 24 Helpline Service Improved Remarkably Says Health Minister 2
18 gauge straight. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation....
Set consist of two 27 gauge, stainless steel probes with Crawford Olive tips. Probes are 11.5 cm (4.5 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attache...
Set consist of two 23 gauge, stainless steel probes with blunt tips. Probes are 18 cm (7.0 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto the ...
Straight, soft flexible tip allows atraumatic entry through a retinal tear or hole for aspiration of subretinal fluids. 20 gauge x 25 mm cannula attached to 25 gauge x 6 mm tip with 13 mm flexible tu...
Medicine Products: